NCT02211898已完成3 期
Clinical Study of BNS003 on Swelling Due to Disorder of Leg Venous Reflux
适应症
干预措施
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 入组人数
- 180
- 主要终点
- Number of patients with adverse drug reactions
研究概览
简要总结
To investigate the efficacy and safety of BNS003 on subjective symptoms such as sensation of heaviness/tiredness(dullness), tension, tingling, pain, fever or itching associated with swelling of calf and ankle due to disorder of leg venous reflux.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 20 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Manifestation of swelling falling into Class 1 according to Porter's classification
- •With more than 2 symptoms of "sensation of heaviness/tiredness (dullness)," "tension," "tingling," "pain," "fever" or "itching" and a total score of >=3 for severity by symptoms
- •Persons aged 20 years or older at the time of obtaining their informed consent and available for hospital visits. Both genders are acceptable
- •Persons who have consented to participating in the study in written form with good understanding of the objective of the study, the methods, and notices for the study period
排除标准
- •Persons with edema not due to venous diseases of the legs (e.g., lymphedema, latent cardiac or renal insufficiency, etc.)
- •Persons with peripheral arterial diseases
- •Persons with acute phlebitis, venous ulcer, congenital vascular anomaly, or Behcet's Syndrome
- •Persons with "moderate" or "severe" renal, hepatic, cardiac or haematological disorder, or with a history of such disorder (Grade 3 or 4 in Common Toxicity Criteria (CTC))
- •Persons with diabetes mellitus (excluding those curable with dietary therapy), neuropathy, hyper-or hypocalcemia, or malignant tumors
- •Persons with drug or alcohol abuse
- •Persons with immobility
- •Persons with pulmonary embolism
- •Persons with hypersensitivity to drugs (particularly to the ingredients contained in the investigational drug)
- •Persons with clinical indication of requiring venous treatment such as physical application (use of elastic bandage and compression stockings) and phlebectomy (vein stripping surgery to remove vein affected with varicosis and valve insufficiency)
- •Persons who received venous sclerosing therapy within the last 4 weeks before starting this study
- •Persons who constantly use theophylline preparations, diuretics, cardiac glycosides
- •Persons who had changed to or initiated post-menopausal hormone replacement therapy within the last 2 months before starting this study
- •Persons unable to suspend the frequent use and exceeded dosage/administration of laxatives (more than 6 times) during the study period
- •Persons planned to undergo a surgery requiring systemic anesthesia during the study period
- •Women in pregnancy or nursing, or those who wish for a pregnancy during the study period
- •Persons who participated in another study within the last 3 months before starting this study, or who plan to participate in another study during the study period
- •Persons who were considered to be ineligible to be a subject for the trial by the investigator or sub-investigators
研究组 & 干预措施
BNS003
Experimental
干预措施: BNS003 (Drug)
结局指标
主要结局
Number of patients with adverse drug reactions
时间窗: up to week 12
Global improvement on a five point scale
时间窗: week 12
The degree of improvement was evaluated according to change of severity of each symptom at the time of enrollment (baseline) and in Week 12 after initiation of dosing (or at discontinuation)
次要结局
- Number of patients with of adverse events(up to 12 weeks)
- Improvement per symptom on a five point scale(12 weeks)
- Subject's impression on improvement on a five point scale(baseline, 12 weeks)
- Change in circumference measurements of ankle in centimetres(baseline, 12 weeks)
- Change in circumference measurements of calf in centimetres(baseline, 12 weeks)
研究者
相似试验
招募中
3 期
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerEndometrial CancerNCT06340568BioNTech SE480
已完成
不适用
Deep Brain Stimulation for the Treatment of Alzheimer's DiseaseAlzheimer's DiseaseNCT01559220Ali Rezai, MD3
终止
不适用
Effects of Noninvasive Brain Stimulation Techniques on BDNF LevelsSchizophreniaDepressionNCT02652832Hôpital le Vinatier165
招募中
不适用
Deep Brain Stimulation of the Cuneiform Nucleus for Levodopa-resistant Freezing of Gait in Parkinson's DiseaseParkinson DiseaseNCT04218526Jonathan Jagid4
招募中
不适用
Evaluation of Deep Brain Stimulation (DBS) of the Right Operculum 3 (OP3) in Permanent Non-pulsatile Disabling Tinnitus (TINNOP3-DBS)Severe Permanent Uni or Bilateral Non-pulsatile TinnitusWithout Associated Vestibular PathologyResistant to Therapeutic FailureWith or Without Hearing LossNCT04296097University Hospital, Grenoble7